The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Rana el Kaliouby, CEO & Cofounder, Affectiva
Rei Goffer, Cofounder & Chief Strategy Officer, ClimaCell
Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Proctor & Gamble is seeking a technology solution to manage the e2e Creative Content Supply chain.
Dr. Cory Kidd, Founder & CEO, Catalia Health